Results

Total Results: 1,169 records

Showing results for "patient safety".

361. EHC Protocol: Updating the Measurement Criteria for AHRQ's National Healthcare Quality and Disparities Report (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/updating-criteria-qdr-protocol.pdf
     September 06, 2023 - include access to care, affordable care, care coordination, effective treatment, healthy living, patient … safety, and person-centered care.1 The report presents the latest available data on care quality and … Sources include patient surveys, provider surveys, administrative data from facilities, and medical … safety, health insurance (end user), digital health, and health information technology, as well as … They may include clinical experts, patients, manufacturers, researchers, payers, or other perspectives

362. Progestogens-Preterm-Birth Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/progestogens-preterm-birth_executive.pdf
     September 01, 2012 - associated with preterm birth represent untold distress for families, as well as significant costs to patients … However, these groups also note interest in assessing long-term safety because the Effective Health … How do the effectiveness, adverse effects, and safety of progestogen treatment differ based on the maternal … How do the effectiveness, acceptability, adherence, adverse effects, and safety of progestogen treatment … One survey addressed patient demand; 63 percent reported that patients “never request”; 35 percent,

363. Disposition of Comments Report for Whole-Body Vibration Therapy for Osteoporosis (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/osteoporosis-vibration-therapy_disposition-comments.pdf
     November 15, 2011 - While we understand the risk for low bone density in patient populations with specific conditions, … the findings to all of these diverse patient populations. … Peer Reviewer #3 Methods This was a review of literature so patient inclusion and exclusion was not … J Bone Miner Res 2008; 23: 1318-25, in the discussion of safety issues. … We have noted this safety concern in our description.

364. Arthritis and Nontraumatic Joint Disease (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/01_-arthritis_potential_high_impact_june_2012.pdf
     January 01, 2012 - These safety concerns may present barriers to approval or barriers to diffusion if approved. … determinations stated MSC therapy is investigational because of insufficient evidence or long-term safety … Both groups had similar safety profiles. 29 In a study of patients with knee OA (Outerbridge grades … as a hospital blood bank or blood processing laboratory) according to standard blood processing safety … These safety concerns may present significant barriers to approval and diffusion if approved.

365. Living Systematic Review on Cannabis and Other Plant-Based Treatments for Chronic Pain: 2023 Update -- Surveillance Report 4 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cannabis-2023-surv-rep-4.pdf
     January 01, 2023 - Cannabis for chronic pain: cardiovascular safety in a nationwide Danish study. … Pharmacokinetics and pharmacodynamics of cannabis- based medicine in a patient population included in … Medicinal cannabis for Australian patients with chronic refractory pain including arthritis.

366. Updating the Measurement Criteria for AHRQ’s National Healthcare Quality and Disparities Report (NHQDR) (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/updating-criteria-qdr-protocol-amendment.pdf
     December 28, 2023 - include access to care, affordable care, care coordination, effective treatment, healthy living, patient … safety, and person-centered care.1 The report presents the latest available data on care quality and … Sources include patient surveys, provider surveys, administrative data from facilities, and medical … safety, health insurance (end user), digital health, and health information technology, as well as … They may include clinical experts, patients, manufacturers, researchers, payers, or other perspectives

367. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/migraine-emergency_research-protocol.pdf
     July 18, 2011 - Patient satisfaction with experience o Adverse effects of intervention(s) a. … Safety: RCTs, NRCTs, and prospective cohort studies. … Patient satisfaction with experience 8. … Exclusion of patients with comorbidities. … Dodick D, Lipton RB, Martin V, et al, for the Triptan Cardiovascular Safety Expert Panel.

368. PEPTIC ULCER #11 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/peptic-ulcer-horizon-scan-high-impact-1312.pdf
     December 01, 2013 - on safety and efficacy. … decide the true efficacy and safety of this device.”31 The potential for patient acceptance would … During the followup period (up to 25 months), no patient reported dysphagia recurrence, but some patients … Summary of safety and effectiveness data (SSED). LINX reflux management system. P100049. … The LINX reflux management system: confirmed safety and efficacy now at 4 years.

369. Layout 1 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/gerd-2005_executive.pdf
     January 01, 2005 - It summarizes the available evidence comparing the efficacy and safety of medical, surgical, and endoscopic … there evidence that effectiveness of medical, surgical, and endoscopic treatments varies for specific patient … Patient characteristics associated with outcomes of medical, surgical, and endoscopic treatments Patients … with GERD should be managed based upon patient characteristics or response to previous therapy. … More efficacy and safety data on new endoscopic approaches tested against a sham procedure with adequate

370. Preventing Complications and Treating Symptoms of Diabetic Peripheral Neuropathy (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/diabetic-neuropathy-disposition-170707.pdf
     March 24, 2017 - report (pain and other outcomes) based input from the technical expert panel and preferentially chose patient-centered … We appreciate this comment noting that a synthesis of safety data may consider other types of data … Addressing the safety of these interventions overall in all types of conditions, rather than their … This broader safety data, such as overall mortality from spinal cord stimulation, is therefore not … moderate SOE) DULOXETINE HELPFUL IN CONJUNCTION WITH GABAPENITIN ALTHOUGH THERE ARE A LOT OF REPORTED PATIENT

371. Preventing Complications and Treating Symptoms of Diabetic Peripheral Neuropathy (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/diabetic-neuropathy-disposition-170707.pdf
     March 24, 2017 - report (pain and other outcomes) based input from the technical expert panel and preferentially chose patient-centered … We appreciate this comment noting that a synthesis of safety data may consider other types of data … Addressing the safety of these interventions overall in all types of conditions, rather than their … This broader safety data, such as overall mortality from spinal cord stimulation, is therefore not … moderate SOE) DULOXETINE HELPFUL IN CONJUNCTION WITH GABAPENITIN ALTHOUGH THERE ARE A LOT OF REPORTED PATIENT

372. #05 DEPRESSION (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/depression-horizon-scan-high-impact-1412.pdf
     December 01, 2014 - Adoption could be limited by ketamine’s cost, inconsistent clinical trial data, and safety risks, multiple … But one expert with a research 5 background, citing ketamine’s safety risk and lack of long-term … be limited; these experts cited ketamine’s safety risks and lack of robust clinical trial data as … In contrast, scopolamine’s known safety profile and possible oral and patch delivery options, bolstered … A study to evaluate the safety and efficacy of intranasal esketamine in treatment-resistant depression

373. DEMENTIA INCLUDING ALZHEIMER'S #04 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/dementia_hi_impact.pdf
     January 01, 2012 - in patients developing AD. … safety and care of the patient … On the other hand, some experts thought that having the diagnosis would enable planing for safety … and care of the patient. … A diagnosis could, however aid patients and families in planning for the care and safety of the patient

374. Methods Research Report: Creating Efficiencies in the Extraction of Data From Randomized Trials (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-report-creating-efficiencies-extraction-data.pdf
     August 01, 2021 - , crossover trial with an open-label safety evaluation period. 5 Efficacy data were analyzed using … ; 14 patients were randomly assigned to intervention and 13 patients to the control group. 2 To compare … rate in pediatric oncology patients. … Evaluation of immunogenicity and safety of VARIVAXTM New Seed Process (NSP) in children. … patients a randomized clinical trial.

375. Executive Summary: ADHD Diagnosis and Treatment in Children and Adolescents (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-267-adhd-executive-summary.pdf
     March 01, 2024 - Commissioned by the Patient-Centered Outcomes Research Institute (PCORI), this review assesses evidence … concerns about treatment strategies, including over- and under-treatment; and how to best monitor ADHD patients … • Despite the large body of research, comparative effectiveness and safety information is limited … Despite the large body of research, comparative effectiveness and safety information is limited. … Studies did not provide information on key comparative effectiveness and safety outcomes, and SoE is

376. S16 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/s16.pdf
     October 01, 2007 - evidence is centered on the protocol-driven ran- domized trials, which the FDA requires to establish safety … information from industry-funded trials may remain unpublished, limiting the ability to examine potential safety … carefully studied in trials (especially rare or slow emerging harms); explore sources of heterogeneity in safety … may depend on severity of strokes, patient preferences. … patients; audits could examine the rates at which women and patients over age 80 are undergoing surgery

377. CER 215 Executive Summary: Adverse Effects of Pharmacologic Treatments of Major Depression in Older Adults (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-215-depression-older-adults-executive-summary.pdf
     March 01, 2019 - Further characterization of the comparative safety of antidepressants is difficult because few studies … Comparative efficacy and safety of sertraline versus nortriptyline in major depression in patients … Safety and tolerability of duloxetine at 60 mg once daily in elderly patients with major depressive … double- blind, placebo-controlled, duloxetine-referenced, fixed-dose study comparing the efficacy and safety … Are old-old patients with major depression more likely to relapse than young-old patients during continuation

378. Disposition of Comments_Technical Brief No. 47: Measuring Documentation Burden in Healthcare (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/documentation-burden-prepub-disposition-comments.pdf
     May 21, 2024 - safety. … A delayed patient safety alert review can adversely impact care. … For information to be effective in better understanding our patients, patient populations, treatment … For information to be effective in better understanding our patients, patient populations, treatment … A great deal of patient clinical histories could be entered and stored by patients themselves, with

379. Management of Suicidal Thoughts and Behaviors in Youth (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/suicidal-thoughts-young-people-amendement.pdf
     February 05, 2025 - regulation and management, behavioral planning, family engagement and communication training, and practical safety … intervals), directness of the evidence to the KQs (focusing on whether the outcomes were important to patients … Intervention research with persons at high risk for suicidality: safety and ethical considerations. … The SAFETY program: a treatment-development trial of a cognitive-behavioral family treatment for adolescent … Key Informants Key Informants are the end-users of research; they can include patients and caregivers

380. Multiple-Sclerosis Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/multiple-sclerosis_executive.pdf
     April 01, 2015 - • Both patient and third-party observers rated physicians as showing limited skill at involving patients … For example, a November 2014 FDA Drug Safety Communication reported the first confirmed fatal case … Cross-sectional study assessing long-term safety of interferon-beta-1b for relapsing- remitting MS. … The long-term safety and tolerability of high-dose interferon beta-1a in relapsing-remitting multiple … Long-term follow- up of a phase 2 study of oral teriflunomide in relapsing multiple sclerosis: safety